Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03232138 · ClinicalTrials.gov registry record · Phase 2

Clinical Trial of Lung Cancer Chemoprevention With Sulforaphane in Former Smokers

A Phase 2 study of Lung Cancer, sponsored by Jian-Min Yuan, MD.

Completed
Registry status
Phase 2
Development phase
43
Enrollment target
1
Study location

NCT03232138: Completed Phase 2 study of Lung Cancer, sponsored by Jian-Min Yuan, MD.

NCT03232138 is a Phase 2 study of Lung Cancer that has completed, run by Jian-Min Yuan, MD. The registered enrollment target is 43 participants, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03232138, a Phase 2 study of Lung Cancer, has completed, sponsored by Jian-Min Yuan, MD.

COMPLETED
Registry status
Phase 2
Development phase
43 participants
Enrollment target
1
Study location

Study Summary

This research study involves taking an experimental anti-cancer dietary supplement called Sulforaphane (SF) or a placebo (product without any supplement content) over a period of twelve months in order to determine if it is a useful dietary supplement for prevention of lung cancer in humans. The main goals of this research study are: 1. To learn about the effects of giving Sulforaphane (SF) to former smokers who are still at high risk of developing cancer due to their smoking history and whether or not their condition improves, stays the same or becomes worse after Sulforaphane (SF) is given. 2. To learn whether Sulforaphane (SF) might reverse some of the lung cell changes associated with future development of lung cancer.

Conditions Studied

Lung Cancer

Interventions

  • DRUG Placebo
  • DIETARY_SUPPLEMENT Sulforaphane

Study Locations (1)

Pennsylvania

  • UPMC Hillman Cancer Center - Pittsburgh

Trial Details

FieldValue
Enrollment Target 43 participants
Start Date 2018-01-25
Est. Completion 2023-02-17
Phase Phase 2

Sponsor

Jian-Min Yuan, MD

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03232138

The ClinicalTrials.gov registry entry for NCT03232138 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (95% lower). The listed sponsor is Jian-Min Yuan, MD, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT03232138 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03232138 about?

NCT03232138 is a clinical study titled "Clinical Trial of Lung Cancer Chemoprevention With Sulforaphane in Former Smokers". This research study involves taking an experimental anti-cancer dietary supplement called Sulforaphane (SF) or a placebo (product without any supplement content) over a period of twelve months in order to determine if it is a useful dietary supplement for prevention of lung cancer in humans. The ma...

What is the current status of trial NCT03232138?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 43 participants. The study started on 2018-01-25. Estimated completion is 2023-02-17.

What conditions does trial NCT03232138 study?

This clinical trial studies the following conditions: Lung Cancer.

What interventions are being tested in trial NCT03232138?

The interventions under investigation include: Placebo (DRUG), Sulforaphane (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03232138?

This trial is sponsored by Jian-Min Yuan, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03232138 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Lung Cancer

All registered trials for this condition

Pennsylvania

All trials with a study site in Pennsylvania

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.